Periodic monitoring Active

Key facts

  • Consultation rates for respiratory illness in both primary and secondary care settings remain at baseline levels across most European Union/European Economic Area (EU/EEA) countries, with only one country reporting activity above baseline. An increase in SARS-CoV-2 circulation is still being observed.
  • SARS-CoV-2 activity is slowly increasing in primary and secondary care in several countries throughout the EU/EEA. Detections in primary care are being reported among individuals aged 15 years and above, while in secondary care, detections are mainly being reported among adults aged over 65 years.
  • Influenza virus activity remains low overall, with only a small number of countries reporting detections. Most detections are influenza A viruses, and hospitalised cases are predominantly among adults aged 65 years and above.
  • Respiratory syncytial virus (RSV) activity is low and at the expected inter-epidemic levels.

Overview

ECDC monitors respiratory illness rates and virus activity across the EU/EEA. Findings are presented in the European Respiratory Virus Surveillance Summary (ERVISS.org), which is updated weekly.

Key visualisation from the weekly bulletin are included below.

All data are provisional and may be affected by reporting delays, incomplete country data or low testing volumes. A few countries with high testing rates can disproportionately influence pooled data. Further information is available under ‘Country notes’ and ‘Additional resources’.

Visualisations

Figure 1. ILI/ARI virological surveillance in primary care - weekly test positivity

Figure 2. SARI virological surveillance in hospitals - weekly test positivity

Figure 3. Key indicators

Figure 4. ILI/ARI virological surveillance in primary care - pathogen type and subtype distribution

Figure 5. SARI virological surveillance in hospitals - pathogen type and subtype distribution

Figure 6. Genetically characterised influenza virus distribution, week 40, 2025 – week 36, 2026

Figure 7. SARS-CoV-2 variant distribution, week 43, 2025 - week 44, 2025

Latest updates for this event

View all